Literature DB >> 22101287

Bile salt composition is secondary to bile salt concentration in determining hydrocortisone and progesterone solubility in intestinal mimetic fluids.

Huda Zughaid1, Ben Forbes, Gary P Martin, Nilesh Patel.   

Abstract

Simulated intestinal fluids (SIFs) used to assay the solubility of orally administered drugs are typically based on a single bile salt; sodium taurocholate (STC). The aim of this study was to develop mimetic intestinal fluids with a closer similarity to physiological fluids than those reported to date by developing a mixed bile salt (MBS) system (STC, sodium glycodeoxycholate, sodium deoxycholate; 60:39:1) with different concentrations of lecithin, the preponderant intestinal phospholipid. Hydrocortisone and progesterone were used as model drugs to evaluate systematically the influence of SIF composition on solubility. Increasing total bile salt concentration from 0 to 30 mM increased hydrocortisone and progesterone solubility by 2- and ∼25-fold, respectively. Accordingly, higher solubilities were measured in the fed-state compared to the fasted-state SIFs. Progesterone showed the greatest increases in solubility in STC and MBS systems (2-7-fold) compared to hydrocortisone (no significant change; P>0.05) as lecithin concentration was increased. Overall, MBS systems gave similar solubility profiles to STC. In conclusion, the addenda of MBS and lecithin were found to be secondary to the influence of BS concentration. These data provide a foundation for the design of more bio-similar media for pivotal decision-guiding assays in drug development and quality control settings.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101287     DOI: 10.1016/j.ijpharm.2011.11.012

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Paediatric pharmacokinetics: key considerations.

Authors:  Hannah Katharine Batchelor; John Francis Marriott
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 2.  Characterising lipid lipolysis and its implication in lipid-based formulation development.

Authors:  Nicky Thomas; René Holm; Thomas Rades; Anette Müllertz
Journal:  AAPS J       Date:  2012-09-07       Impact factor: 4.009

3.  Effect of co-encapsulation using a calcium alginate matrix and fructooligosaccharides with gelatin coating on the survival of Lactobacillus paracasei cells.

Authors:  Rosetânia Correia Neves da Conceição; Rayssa Dias Batista; Fernanda Munhoz Dos Anjos Leal Zimmer; Ianna Kelly Martins Trindade; Alex Fernando de Almeida; Claudia Cristina Auler do Amaral Santos
Journal:  Braz J Microbiol       Date:  2021-04-10       Impact factor: 2.476

4.  Optimizing Prednisolone Loading into Distiller's Dried Grain Kafirin Microparticles, and In vitro Release for Oral Delivery.

Authors:  Esther T L Lau; Stuart K Johnson; Barbara A Williams; Deirdre Mikkelsen; Elizabeth McCourt; Roger A Stanley; Ram Mereddy; Peter J Halley; Kathryn J Steadman
Journal:  Pharmaceutics       Date:  2017-05-19       Impact factor: 6.321

5.  Towards an Understanding of the Low Bioavailability of Quercetin: A Study of Its Interaction with Intestinal Lipids.

Authors:  Gillian T Rich; Maria Buchweitz; Mark S Winterbone; Paul A Kroon; Peter J Wilde
Journal:  Nutrients       Date:  2017-02-05       Impact factor: 5.717

6.  Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid.

Authors:  Qamar Abuhassan; Ibrahim Khadra; Kate Pyper; Gavin W Halbert
Journal:  Eur J Pharm Biopharm       Date:  2021-08-20       Impact factor: 5.571

Review 7.  Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery.

Authors:  Maisarah Azman; Akmal H Sabri; Qonita Kurnia Anjani; Mohd Faiz Mustaffa; Khuriah Abdul Hamid
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.